Design Therapeutics, Inc. (DSGN) Financials
DSGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 299.9 million | 14.9 million |
| 2023-06-30 | 311.6 million | 14.8 million |
| 2023-03-31 | 324.7 million | 11.9 million |
| 2022-12-31 | 341.1 million | 13.8 million |
DSGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -14.6 million | 3.2 million |
| 2023-06-30 | -13.9 million | 3.7 million |
| 2023-03-31 | -17.5 million | 3.4 million |
| 2022-12-31 | -15.4 million | 3.1 million |
DSGN Net Income
No data available :(
DSGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 290.9 million | - | 3.2 million |
| 2023-06-30 | 303.1 million | - | 3.4 million |
| 2023-03-31 | 315.4 million | - | 2.9 million |
| 2022-12-31 | 330.4 million | - | 3.7 million |
DSGN Shares Outstanding
DSGN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 53000 | 13.3 million | 5.6 million | - |
| 2023-06-30 | 89000 | 17.1 million | 5.5 million | - |
| 2023-03-31 | 87000 | 15.7 million | 5.9 million | - |
| 2022-12-31 | 288000 | 14.3 million | 5.1 million | - |
DSGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 137000 |
| 2023-06-30 | - | 143000 |
| 2023-03-31 | - | 139000 |
| 2022-12-31 | - | 135000 |
DSGN
Price: $4.36
52 week price:
Earnings Per Share: -1.16 USD
P/E Ratio: -1.78
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 301800
Market Capitalization: 213.0 million